Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...

Much hype surrounds drugs called GLP-1 agonists but they are intended for diabetes patients and people who are obese, not ...

About 45% of households with tuberculosis (TB) patients suffered catastrophic costs--defined here as expenditure that is more ...

LONDON, GREATER LONDON, UNITED KINGDOM, December 16, 2024 /EINPresswire / -- The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only!

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Proteomics International has topped up its coffers with a $2.16m Australian R&D tax rebate to further support the launch of three innovative, simple blood tests.